510(k) K032796
K032796 is an FDA 510(k) premarket notification submitted by Ibl GmbH for the device "IBL C3D-CIC EIA TEST". The FDA issued a decision of Substantially Equivalent on January 13, 2004. The device falls under product code CZW (Complement C3, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Ibl GmbH has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 13, 2004
- Date Received
- September 8, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C3, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5240
- Review Panel
- IM
- Submission Type